These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Successful treatment of type 1 pityriasis rubra pilaris with ustekinumab therapy. Ruiz Villaverde R; Sánchez Cano D Eur J Dermatol; 2010; 20(5):630-1. PubMed ID: 20605773 [No Abstract] [Full Text] [Related]
43. Successful treatment of pityriasis rubra pilaris with oral Vitamin A in oil (Chocola A(®) ) for an 18-month-old child. Kan Y; Sumikawa Y; Yamashita T J Dermatol; 2015 Dec; 42(12):1210-1. PubMed ID: 26387659 [No Abstract] [Full Text] [Related]
44. Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. Borok M; Lowe NJ J Am Acad Dermatol; 1990 May; 22(5 Pt 1):792-5. PubMed ID: 2347965 [TBL] [Abstract][Full Text] [Related]
45. Erythroderma exfoliativa (secondary to pityriasis rubra pilaris?) in a nine-year-old girl. ROTHMAN S; MARSHAK LC AMA Arch Derm Syphilol; 1951 Jul; 64(1):102-3. PubMed ID: 14837517 [No Abstract] [Full Text] [Related]
46. Response of juvenile circumscribed pityriasis rubra pilaris to topical tazarotene treatment. Karimian-Teherani D; Parissa M; Tanew A Pediatr Dermatol; 2008; 25(1):125-6. PubMed ID: 18304175 [TBL] [Abstract][Full Text] [Related]
47. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. Ruzzetti M; Saraceno R; Carboni I; Papoutsaki M; Chimenti S J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):117-8. PubMed ID: 18181990 [No Abstract] [Full Text] [Related]
54. Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra Pilaris. Halper K; Wright B; Maloney NJ; Kim MM; Ravi V; Worswick S; Lei DK JAMA Dermatol; 2020 Dec; 156(12):1373-1374. PubMed ID: 32965475 [TBL] [Abstract][Full Text] [Related]